This article explores common challenges faced by flow cytometry users, such as fluorochrome selection, the utility of tandem ...
News Medical on MSN2d
New antibody reduces tumor growth in treatment-resistant breast, ovarian cancers: StudyImmunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced participation in the ...
Panel recommends ICMR to hold inter-ministerial consultation on patent duration: Gireesh Babu, New Delhi Saturday, March 15, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Healt ...
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined IQVIA to conduct the bioequivalence study or present safety data for ...
Innovation never stops at Celluma. Following the successful launch of our next-generation Series 2 devices in September 2024, BioPhotas is proud to introduce the first new light therapy solution for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback